Russell Barrans, Chief Commercial Officer at Evofem Biosciences, Inc. (EVFM), sold 1,578 shares at $6.50 ($10K) on 2020-01-16, disclosed to the SEC on 2020-01-21.
Scheduled sale ($10k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EVFM | SELL | 2020-02-21 | $194K | — | Filing → |
| EVFM | BUY | 2018-11-26 | $990 | — | Filing → |
| EVFM | BUY | 2018-08-13 | $7K | — | Filing → |